ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
125.401,38
-1,36%
S&P 500
5.983,25
-0,50%
US Dollar vs BRL
5,8283
0,85%
Bitcoin
87.882,84
-3,89%
Brent Oil
74,265
-0,30%
As Melhores Corretoras Online
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Abeona Therapeutics Inc (ABEO)

  7. Abeona Therapeutics Inc (ABEO) Notícias

ABEO

Abeona Therapeutics (ABEO)

Abeona Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ABEO
DataHoraFonteTítuloCódigoCompanhia
03/02/202522:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
03/02/202509:30GlobeNewswire Inc.Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ABEOAbeona Therapeutics Inc
29/01/202518:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
06/01/202519:09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ABEOAbeona Therapeutics Inc
20/12/202418:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABEOAbeona Therapeutics Inc
14/11/202421:56Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ABEOAbeona Therapeutics Inc
14/11/202409:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABEOAbeona Therapeutics Inc
14/11/202409:30GlobeNewswire Inc.Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate UpdatesNASDAQ:ABEOAbeona Therapeutics Inc
12/11/202419:24Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ABEOAbeona Therapeutics Inc
12/11/202409:30GlobeNewswire Inc.Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis BullosaNASDAQ:ABEOAbeona Therapeutics Inc
04/11/202409:30GlobeNewswire Inc.Abeona Therapeutics® Announces Participation in November Investor ConferencesNASDAQ:ABEOAbeona Therapeutics Inc
29/10/202408:30GlobeNewswire Inc.Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug AdministrationNASDAQ:ABEOAbeona Therapeutics Inc
03/09/202408:30GlobeNewswire Inc.Abeona Therapeutics® Announces Participation in Upcoming Investor ConferencesNASDAQ:ABEOAbeona Therapeutics Inc
14/08/202418:08Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
14/08/202408:30GlobeNewswire Inc.Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of DirectorsNASDAQ:ABEOAbeona Therapeutics Inc
13/08/202408:30GlobeNewswire Inc.Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-celNASDAQ:ABEOAbeona Therapeutics Inc
12/08/202408:30GlobeNewswire Inc.Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA ResubmissionNASDAQ:ABEOAbeona Therapeutics Inc
11/07/202408:30GlobeNewswire Inc.Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology IndicationsNASDAQ:ABEOAbeona Therapeutics Inc
08/07/202408:30GlobeNewswire Inc.Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy ForumNASDAQ:ABEOAbeona Therapeutics Inc
17/06/202418:17Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:ABEOAbeona Therapeutics Inc
12/06/202408:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ABEOAbeona Therapeutics Inc
03/06/202417:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ABEOAbeona Therapeutics Inc
03/06/202408:30GlobeNewswire Inc.Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ABEOAbeona Therapeutics Inc
28/05/202408:30GlobeNewswire Inc.Abeona Therapeutics to Present at the Jefferies Global Healthcare ConferenceNASDAQ:ABEOAbeona Therapeutics Inc
15/05/202408:30GlobeNewswire Inc.Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate ProgressNASDAQ:ABEOAbeona Therapeutics Inc
13/05/202418:03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ABEOAbeona Therapeutics Inc
03/05/202408:30GlobeNewswire Inc.Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsNASDAQ:ABEOAbeona Therapeutics Inc
22/04/202417:05GlobeNewswire Inc.Abeona Therapeutics Provides Regulatory Update on Pz-celNASDAQ:ABEOAbeona Therapeutics Inc
18/03/202408:30GlobeNewswire Inc.Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA InspectionsNASDAQ:ABEOAbeona Therapeutics Inc
01/02/202409:30GlobeNewswire Inc.Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)NASDAQ:ABEOAbeona Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ABEO

Seu Histórico Recente

AMEX
HEZU
iShares Currency Hedged ...
LSE
WCLD
Wt Cloud Usd
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios